MannKind (MNKD) News Today $5.39 +0.02 (+0.37%) Closing price 09/17/2025 04:00 PM EasternExtended Trading$5.36 -0.02 (-0.46%) As of 05:04 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MNKD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period MannKind (NASDAQ:MNKD) Stock Price Down 4.2% - Time to Sell?September 16 at 6:22 PM | marketbeat.comSCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPHSeptember 16 at 12:17 PM | businesswire.comGoldman Sachs Group Inc. Sells 780,939 Shares of MannKind Corporation $MNKDSeptember 16 at 4:10 AM | marketbeat.comMillennium Management LLC Acquires 2,375,198 Shares of MannKind Corporation $MNKDSeptember 13, 2025 | marketbeat.comMannKind Corporation (MNKD) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comMannKind (MNKD): A Fresh Look at Valuation Following New United Therapeutics Deal ExpansionSeptember 10, 2025 | finance.yahoo.comJacobs Levy Equity Management Inc. Boosts Stock Position in MannKind Corporation $MNKDSeptember 10, 2025 | marketbeat.comMannKind Corporation $MNKD Shares Sold by Parkman Healthcare Partners LLCSeptember 8, 2025 | marketbeat.comMannKind Corporation (NASDAQ:MNKD) Receives Average Recommendation of "Buy" from BrokeragesSeptember 8, 2025 | marketbeat.comOppenheimer Forecasts Strong Price Appreciation for MannKind (NASDAQ:MNKD) StockSeptember 8, 2025 | americanbankingnews.comMannKind Corporation (MNKD) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptSeptember 7, 2025 | seekingalpha.comMannKind Corporation (MNKD) Presents At Cantor Global Healthcare Conference 2025 TranscriptSeptember 7, 2025 | seekingalpha.comMannKind Corporation $MNKD Stake Decreased by Nitorum Capital L.P.September 7, 2025 | marketbeat.comPDT Partners LLC Makes New Investment in MannKind Corporation $MNKDSeptember 7, 2025 | marketbeat.comMannKind Corporation (NASDAQ:MNKD) Given Consensus Rating of "Buy" by AnalystsSeptember 7, 2025 | americanbankingnews.comMannKind (NASDAQ:MNKD) Shares Up 7.4% Following Analyst UpgradeSeptember 7, 2025 | americanbankingnews.comFY2028 EPS Estimates for MannKind Boosted by HC WainwrightSeptember 6, 2025 | marketbeat.comMannKind Corporation $MNKD Shares Sold by Northern Trust CorpSeptember 6, 2025 | marketbeat.comWells Fargo & Company Forecasts Strong Price Appreciation for MannKind (NASDAQ:MNKD) StockSeptember 5, 2025 | marketbeat.comState of Wyoming Boosts Position in MannKind Corporation $MNKDSeptember 5, 2025 | marketbeat.comMannKind Corporation $MNKD Shares Bought by Trexquant Investment LPSeptember 5, 2025 | marketbeat.comMannKind (NASDAQ:MNKD) Shares Gap Up After Analyst UpgradeSeptember 4, 2025 | marketbeat.comHC Wainwright Issues Positive Forecast for MannKind (NASDAQ:MNKD) Stock PriceSeptember 4, 2025 | marketbeat.comInvestors Buy High Volume of Call Options on MannKind (NASDAQ:MNKD)September 4, 2025 | marketbeat.comPositive TETON-2 Study Results Drive Buy Rating and Price Target Increase for MannKindSeptember 2, 2025 | tipranks.comUnited Therapeutics succeeds in late-stage trial for Tyvaso against lung disorderSeptember 2, 2025 | msn.comWellington Management Group LLP Reduces Stock Position in MannKind Corporation $MNKDSeptember 1, 2025 | marketbeat.comRussell Investments Group Ltd. Cuts Position in MannKind Corporation $MNKDSeptember 1, 2025 | marketbeat.comMannKind (NASDAQ:MNKD) Stock Price Up 10.4% on Analyst UpgradeAugust 29, 2025 | marketbeat.comInvesco Ltd. Grows Position in MannKind Corporation $MNKDAugust 29, 2025 | marketbeat.comMannKind to Present at Upcoming Investor ConferencesAugust 27, 2025 | globenewswire.comMannKind (NASDAQ:MNKD) Stock Price Down 5.2% - Here's What HappenedAugust 27, 2025 | marketbeat.comMannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled TherapyAugust 27, 2025 | markets.businessinsider.comMannKind Corporation Collaborates with United Therapeutics to Develop Second Dry Powder Inhalation TherapyAugust 27, 2025 | quiverquant.comQMannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled TherapyAugust 27, 2025 | globenewswire.comSCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPHAugust 26, 2025 | businesswire.comVanguard Group Inc. Acquires 1,263,622 Shares of MannKind Corporation $MNKDAugust 26, 2025 | marketbeat.comMannKind Corporation (MNKD) Mergers and Acquisition Call TranscriptAugust 25, 2025 | seekingalpha.comMannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million DealAugust 25, 2025 | benzinga.comMannKind’s Strategic Acquisition of scPharmaceuticals: A Catalyst for Future Growth and Value CreationAugust 25, 2025 | tipranks.comMannKind (MNKD) to Acquire scPharmaceuticals for $360 MillionAugust 25, 2025 | gurufocus.comMannKind’s Strategic Acquisition and Growth Prospects: A Buy Rating by Yun ZhongAugust 25, 2025 | tipranks.comMannKind to buy scPharmaceuticals to expand its cardiometabolic businessAugust 25, 2025 | seekingalpha.comMannKind to Buy ScPharmaceuticals for Up to $360 MillionAugust 25, 2025 | marketwatch.comShareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public ShareholdersAugust 25, 2025 | mms.businesswire.comMannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a ...August 25, 2025 | gurufocus.comMannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a ...August 25, 2025 | gurufocus.comMannKind Announces Acquisition of scPharmaceuticalsAugust 25, 2025 | tipranks.comscPharmaceuticals Announces Merger with MannKind CorporationAugust 25, 2025 | tipranks.comMannKind Corporation Announces Strategic Acquisition of scPharmaceuticals to Enhance Cardiorenal Medicine PortfolioAugust 25, 2025 | quiverquant.comQ Get MannKind News Delivered to You Automatically Sign up to receive the latest news and ratings for MNKD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MNKD Media Mentions By Week MNKD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MNKD News Sentiment▼1.240.92▲Average Medical News Sentiment MNKD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MNKD Articles This Week▼66▲MNKD Articles Average Week Get the Latest News and Ratings for MNKD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for MannKind and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Repligen News Alkermes News Ligand Pharmaceuticals News Amicus Therapeutics News BioCryst Pharmaceuticals News Celldex Therapeutics News Novavax News Innoviva News OPKO Health News Dynavax Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MNKD) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredReagan’s former tech advisor sharing bombshell announcementGeorge Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MannKind Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share MannKind With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MNKD Stock Alerts